European Shares Gain as Genmab Jumps, Bond Yields Retreat
Genmab rose 7.6% after late-stage trial results with AbbVie, helping healthcare stocks lift the broader sector 1.6%, Reuters reported.
7 Articles
7 Articles
Global Market: European shares rally as healthcare gains offset eurozone fiscal concerns
European shares climbed to near one-week highs, led by healthcare stocks, while easing eurozone bond yields offered some relief. Investors remained focused on fiscal pressures, political uncertainty and upcoming economic data for clues on the region’s outlook.
European stocks hit a near-week high in early trade on Tuesday, with Genmab leading the health sector's gains. The pan-European STOXX 600 rose 0.8% to 638.41 at 10:27 a.m. ET, on track for a third straight day of gains. Danish biotech Genmab jumped 7.6%, with the broader healthcare sector up 1.6%. The euro was near a 17-month low amid political uncertainty after Prime Minister Pedro Sanchez called for snap elections in Spain. ΑΠΕ-ΜΑΝ Read more a…
Genmab "leads" the Stoxx with a 7.6% jump.
Coverage Details
Bias Distribution
- 60% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
